Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
216 new pulmonary tuberculosis patients suffering from multiple drug resistance (MDR) were examined. The patients were divided into 2 groups. The first group consisted of 164 patients in whom when admitted to hospital, GeneXpert MTB/RIF was used to test the resistance of Mycobacterium tuberculosis (...
Main Authors: | R. Yu. Аbdullаev, O. G. Komissаrovа, E. S. Chumаkovа, V. S. Odinets, A. E. Ergeshov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2019-08-01
|
Series: | Туберкулез и болезни лёгких |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/1311 |
Similar Items
-
Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01) -
Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
by: E. V. Vаniev, et al.
Published: (2018-11-01) -
EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01) -
Drug susceptibility of M. tuberculosis in tuberculosis patients from various population groups in Khanty-Mansiyskiy Autonomous Region
by: Yu. V. Reshetnikova, et al.
Published: (2015-11-01) -
The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)